Electronic Skin Patch Market Size, Share & Industry Growth Analysis Report by Type (Monitoring & Diagnostic, Therapeutic), Wireless Connectivity (Connected, Non-connected), Application (Diabetes Management, Cardiovascular Monitoring, Temperature Sensing), End User and Region - Global Forecast to 2029
Updated on : October 22, 2024
Electronic Skin Patch Market Size & Growth
The Electronic Skin Patch market size was valued at USD 15.0 billion in 2024 and is estimated to reach USD 27.0 billion by 2029, growing at a CAGR of 12.5% between 2024 to 2029.
The growth of market is driven by the Surging demand for remote health monitoring solutions, Rapid advancements in flexible electronics, sensors and wireless technologies, growing awareness about early disease detection, and rising geriatric population.
Electronic Skin Patch Market Forecast to 2029
To know about the assumptions considered for the study, Request for Free Sample Report
Electronic Skin Patch Market Trends and Dynamics
Driver: Surging demand for remote health monitoring solutions.
The healthcare industry is adopting a new approach to monitoring through remote patient monitoring (RPM). This method involves monitoring patients’ health outside of traditional clinical settings, offering benefits for patients and healthcare providers. Electronic skin patches are emerging as a game-changer in this area due to their comfortable and advanced sensing capabilities. They play a critical role in managing chronic diseases, post-operative care, and eldercare, allowing healthcare providers to remotely monitor patients’ health status and intervene proactively, if necessary. Electronic skin patches are designed with integrated glucose sensors, which can continuously monitor blood sugar levels in real time. This data is valuable for diabetic patients to manage their condition effectively, adjust insulin doses as needed, and prevent complications, such as hypoglycemia or hyperglycemia. Companies, including Dexcom and Abbott Laboratories, have developed continuous glucose monitoring (CGM) systems that utilize electronic skin patches, contributing to the expansion of the electronic skin patch market share.
Restraint: Data privacy and security issues
The electronic skin patch market holds immense potential for revolutionizing healthcare. However, concerns about data security and privacy pose a significant hurdle to widespread adoption. These patches collect sensitive health data, making robust security measures crucial for user trust and market growth. Electric skin patches collect a range of personal health data, including heart rate, blood sugar levels, and even brain activity. This data can reveal intimate details about a person’s health. Therefore, it is paramount to secure its storage and transmission to prevent cybercriminals from exploiting vulnerabilities.
Opportunity: Rising emphasis on improving accuracy of health monitoring patches
The electronic skin patch market share is expanding with the emergence of new and innovative skin patches aimed at a range of health conditions and functionalities. These patches offer solutions to a broader spectrum of health concerns, appealing to a larger audience. By diversifying their applications, electronic skin patches cater to various demographic groups and medical needs, increasing the potential customer base and driving the market. Advancements in skin patch technology have led to enhancements in their functionality and user experience. These patches boast increased accuracy and reliability in data collection, continuous monitoring capabilities, and non-invasive, painless application methods. In October 2023, BioIntelliSense unveiled the BioSticker+, a health monitoring patch with improved accuracy for temperature, heart rate, and respiration monitoring. This patch boasts a comfortable design and extended wear time up to 7 days..
Challenge: Data overload and limited processing power
Electronic skin patches are designed to collect real-time data on various parameters, such as heart rate, blood pressure, temperature, and humidity. These patches continuously monitor physiological and environmental factors, generating streams of data that require rapid analysis and interpretation. However, e-skins typically rely on off-patch processing units for data analysis, which presents various limitations. For instance, continuous wireless data transmission significantly increases power consumption, leading to a shorter battery life. Additionally, it introduces latency, which hinders real-time applications, such as critical health parameter monitoring. Transmitting sensitive bio-signals also raises security concerns regarding data interception. Managing such vast quantities of data in real time poses a considerable computational burden, especially considering the limited processing power available within the small form factor of an electronic skin patch.
Electronic skin Patch Ecosystem
Electronic Skin Patch Market Segmentation
The market for Monitoring & Diagnostics segment to hold largest market share during the forecast period.
Monitoring & Diagnostics accounts for major share in the electronic skin patch market in the forecast period. With conditions, such as stroke and heart failure, projected to skyrocket, innovative monitoring technologies become paramount. These systems offer real-time insights, enabling timely interventions and improved patient outcomes. The American College of Cardiology predicts significant increases in cardiovascular risk factors and diseases in the US by 2060. Stroke and heart failure are expected to see the highest percentage increases, 33.8% to 15 million and 33.4% to 13 million, respectively, from 2025 to 2060. As the prevalence of heart-related conditions continues to climb, there will be a heightened demand for continuous monitoring and innovative interventions to safeguard patient well-being and mitigate the escalating burden on healthcare systems, driving the demand for electronic skin patches.
Connected segment to grow at the highest CAGR in the Wireless connectivity in the electronic skin patch market during the forecast period.
The prevalence of cardiovascular diseases (CVDs) and diabetes has been steadily rising, contributing to a growing need for continuous monitoring solutions, accelerating the market for connected electronic skin patches. The 2023 World Heart Federation (WHF) highlights a concerning global trend of cardiovascular disease (CVD), revealing a 60% surge in CVD deaths over the last three decades. According to the American College of Cardiology Foundation, global death counts due to CVD increased from 12.4 million in 1990 to 19.8 million in 2022. As per the International Diabetes Federation (IDF), approximately 537 million adults aged 20–79 will be living with diabetes in 2021, with this number expected to rise to 643 million by 2030. This increasing burden underscores the importance of effective monitoring to manage and mitigate the risks associated with these diseases.
Diabetes Management segment in application to the highest market share of the electronic skin patch market during the forecast period
Increasingly sedentary lifestyle, obesity, and an aging population are some of the factors that escalates the demand for innovative solutions in diabetes management. Electronic skin patches offer a promising avenue for addressing the unique needs of diabetic patients. With advantages, such as targeted drug delivery, convenience, and reduced side effects, these patches are poised to revolutionize diabetic care. Increasing diabetes awareness, rising healthcare expenditure, and a strong emphasis on patient-centric care further fuel this growth trajectory.
Healthcare segment in application to the highest market share of the electronic skin patch market during the forecast period
The increasing prevalence of chronic diseases has put significant pressure on hospitals and clinics to find innovative solutions to manage patient care more efficiently. According to the World Health Organization (WHO), chronic diseases are responsible for a large proportion of global deaths, with cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes being the leading causes. These diseases account for approximately 73% of all deaths worldwide, with cardiovascular diseases alone responsible for around 18.6 million deaths annually by 2023. The adoption of electronic skin patches for general patient monitoring is increasing due to a growing focus on preventative healthcare and improved patient outcomes. This trend is driven by the wider adoption of remote patient monitoring technologies and the convenience offered by electronic skin patches.
Electronic Skin Patch Industry Regional Analysis
The Electronic skin patch industry in North America is estimated to account for largest share during the forecast period.
North America includes the US, Canada, and Mexico. The market is driven with the increase in consolidation of healthcare providers, widespread adoption of clinical device connectivity & interoperability solutions to curtail the rising healthcare costs, and the rise in the number of heat and diabetic patients in the US. Stringent regulations and guidelines, including the Health Insurance Portability and Accountability Act (HIPPA) and Digital Imaging and Communications in Medicine (DICOM), laid down by government and non-government authorities, such as the Federal Communications Commission (FCC) and the Centers for Medicare and Medicaid Services (CMS) contribute to the dominance of this region.
Electronic Skin Patch Market by Region
To know about the assumptions considered for the study, download the pdf brochure
Top Electronic Skin Patch Companies - Key Market Players
Major vendors in the Electronic Skin Patch Companies include
- Abbott (US),
- Dexcom, Inc. (US),
- Medtronic (Ireland),
- Insulet Corporation (US),
- Boston Scientific Corporation (US),
- Koninklijke Philips N.V. (Netherlands),
- Biolinq Incorporated (US),
- Zio By iRhythm Technologies, Inc. (US),
- GENTAG, Inc. (US),
- VitalConnect (US),
- The Surgical Company (Netherlands),
- Senseonics Ltd. (US),
- Active Environmental Solutions (Australia),
- ScottCare (US),
- VivaLNK, Inc. (US),
- Bittium (Finland),
- Cardiomo (US),
- Seers Technology (South Korea),
- SIGKNOW (Taiwan),
- Cortrium (Denmark),
- Qardio, Inc. (US),
- LifeSignals (US),
- Blue Spark Technologies, Inc. (US),
- Epicore Biosystems (US),
- HIVOX BIOTEK INC. (US),
- IontoPatch (US) are among a few emerging companies in the Electronic Skin Patch market.
Electronic Skin Patch Market Report Scope
Report Metric |
Details |
Estimated Value |
USD 15.0 billion in 2024 |
Expected Value |
USD 27.0 billion by 2029 |
Growth Rate |
CAGR of 12.5% |
Market size available for years |
2020-2029 |
Base year |
2023 |
Forecast period |
2024-2029 |
Segments covered |
Type, Wireless Connectivity, Application, End User, and Region |
Geographic regions covered |
North America, Europe, Asia Pacific, and RoW |
Companies covered |
The major players include Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia) and Others- total 26 players have been covered. |
Electronic Skin Patch Market Highlights
This research report categorizes the Electronic Skin Patch market into Type, Wireless Connectivity, Application, End User, and Region.
Segment |
Subsegment |
By Type: |
|
By Wireless Connectivity: |
|
By Application: |
|
By End User: |
|
By Region: |
|
Recent Developments in Electronic Skin Patch Industry
- In March 2024, Dexcom, Inc. introduced its latest continuous glucose monitoring (CGM) system, Dexcom ONE+, in Ireland. Leveraging its top-tier sensor design and incorporating user and healthcare professional feedback, Dexcom ONE+ offers an easy-to-use and highly effective CGM experience for individuals managing Type 1 or Type 2 diabetes with insulin. Studies also indicate cost savings for health services treating individuals with Type 1 diabetes.
- In August 2023, Insulet Corporation announced the full market release of its Omnipod 5 Automated Insulin Delivery System in Germany, expanding its availability beyond the US. The UK Omnipod 5, the first CE-marked tubeless automated insulin delivery system, integrates with the Dexcom G6 Continuous Glucose Monitoring System. SmartAdjust technology and a SmartBolus Calculator offer automated insulin delivery to manage glucose levels, enhancing diabetes management for individuals aged two years and older with type 1 diabetes.
Key Questions Addressed in the Report:
What is the total CAGR expected to be recorded for the electronic skin patch market size during 2024-2029?
The global electronic skin patch market is expected to record a CAGR of 12.5% from 2024-2029.
Which regions are expected to pose significant demand for the electronic skin patch market share from 2024-2029?
North America & Europe are expected to pose significant demand from 2024 to 2029. Major economies such as US, Germany, China, Japan are expected to have a high potential for the future growth of the market.
What are the major market opportunities for the electronic skin patch market share?
Rising emphasis on improving accuracy of health monitoring patches, increasing application beyond traditional healthcare, and Growing awareness about early disease detection are the significant market opportunities in the electronic skin patch market during the forecast period.
Which are the significant players operating in the electronic skin patch market?
Key players operating in the electronic skin patch market are Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia)
What are the major applications of the electronic skin patch market?
Diabetes Management, Cardiovascular Monitoring, General Patient Monitoring are the major application of electronic skin patch market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
- 5.1 INTRODUCTION
-
5.2 MARKET DYNAMICSDRIVERS- Increasing burden of chronic diseases- Surging demand for remote health monitoring solutions- Rising geriatric population- Rapid advancement in flexible electronics, sensors, and wireless technologiesRESTRAINTS- Data privacy and security issues- High upfront and production costsOPPORTUNITIES- Rising emphasis on improving accuracy of health monitoring devices- Expanding applications of electronic skin patches beyond traditional healthcare- Growing importance of detecting diseases at early stageCHALLENGES- Data overload and limited processing power- Complex regulatory environments
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
-
5.4 PRICING ANALYSISINDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPEAVERAGE SELLING PRICE TREND, BY REGION
- 5.5 VALUE CHAIN ANALYSIS
- 5.6 ECOSYSTEM ANALYSIS
- 5.7 INVESTMENT AND FUNDING SCENARIO
-
5.8 TECHNOLOGY ANALYSISKEY TECHNOLOGIES- Miniaturized sensors- Biocompatible materials and adhesivesCOMPLEMENTARY TECHNOLOGIES- Artificial intelligence (AI) and Internet of Things (IoT)- Data encryption and security protocols- Cloud computingADJACENT TECHNOLOGIES- Wearable electronics- Telemedicine
- 5.9 PATENT ANALYSIS
-
5.10 TRADE ANALYSISIMPORT SCENARIO (HS CODE 901890)EXPORT SCENARIO (HS CODE 901890)
- 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
-
5.12 CASE STUDY ANALYSISCOVESTRO ENABLES EFFECTIVE MONITORING OF VITAL SIGNS AND HEALTH PARAMETERS USING SENSOR-BASED WEARABLE PATCHESDUPONT ADDRESSES LONG-TERM MONITORING CHALLENGES WITH NIGHTHAWK SMART PATCHESMEDHERANT ENSURES ENHANCED DRUG DELIVERY BY LEVERAGING TEPI PATCH TECHNOLOGYNANOTECH SOLUTIONS ENABLES USERS ACHIEVE HIGH SENSIVITY AND SPECIFICITY USING ADVANCED PATCHES EQUIPPED WITH NANOMATERIAL-BASED SENSORSTAPE CONVERTERS HOLLAND B.V. ENABLES CONTINUOUS MONITORING OF HYDRATION LEVELS WITH SMART PATCHES
-
5.13 REGULATORY LANDSCAPEREGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONSSTANDARDS
-
5.14 PORTER’S FIVE FORCES ANALYSISTHREAT OF NEW ENTRANTSTHREAT OF SUBSTITUTESBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERSINTENSITY OF COMPETITIVE RIVALRY
-
5.15 KEY STAKEHOLDERS AND BUYING CRITERIAKEY STAKEHOLDERS IN BUYING PROCESSBUYING CRITERIA
- 6.1 INTRODUCTION
-
6.2 MONITORING & DIAGNOSTICRAPID ADVANCEMENT IN SENSOR TECHNOLOGY TO ACCELERATE SEGMENTAL GROWTH
-
6.3 THERAPEUTICREQUIREMENT FOR PRECISE MONITORING OF PATIENTS WITH CARDIOVASCULAR DISEASES TO BOOST SEGMENTAL GROWTH
- 7.1 INTRODUCTION
-
7.2 CONNECTEDRAPID INNOVATION IN AI AND IOT TECHNOLOGIES TO CONTRIBUTE TO SEGMENTAL GROWTH
-
7.3 NON-CONNECTEDENFORCEMENT OF REGULATIONS TO SAFEGUARD PATIENT HEALTH INFORMATION TO FACILITATE SEGMENTAL GROWTH
- 8.1 INTRODUCTION
-
8.2 DIABETES MANAGEMENTPREFERENCE FOR NON-INVASIVE AND CONTINUOUS GLUCOSE MONITORING SYSTEMS TO DRIVE MARKET
-
8.3 CARDIOVASCULAR MONITORINGREQUIREMENT FOR TIMELY INTERVENTION AND TREATMENT OF HEART DISEASES TO FUEL SEGMENTAL GROWTH
-
8.4 GENERAL PATIENT MONITORINGUSE OF REMOTE MONITORING SOLUTIONS TO DETECT EARLY WARNING SIGNS TO BOOST SEGMENTAL GROWTH
-
8.5 TEMPERATURE SENSINGADOPTION OF SKIN PATCHES TO PREVENT HYPOTHERMIA AND HYPERTHERMIA IN PRETERM INFANTS TO PROPEL MARKET
-
8.6 ELECTRICAL STIMULATIONUSE OF NON-INVASIVE DEVICES IN CHRONIC PAIN AND MUSCULOSKELETAL CONDITION MANAGEMENT TO BOOST SEGMENTAL GROWTH
-
8.7 IONTOPHORESISPREFERENCE FOR ONE-STEP DRUG ADMINISTRATION FOR TREATING INFLAMMATION TO AUGMENT SEGMENTAL GROWTH
-
8.8 SWEAT SENSINGUSE OF ADVANCED MONITORING SYSTEMS BY ATHLETES AND FITNESS ENTHUSIASTS TO CONTRIBUTE TO SEGMENTAL GROWTH
-
8.9 WOUND MONITORING & TREATMENTIMPLEMENTATION OF ADVANCED TECHNOLOGIES TO TREAT CHRONIC WOUNDS TO BOOST SEGMENTAL GROWTH
-
8.10 MOTION SENSINGIMPLEMENTATION OF REMOTE MONITORING AND TELEHEALTH INITIATIVES TO CONTRIBUTE TO SEGMENTAL GROWTH
- 8.11 OTHER APPLICATIONS
- 9.1 INTRODUCTION
-
9.2 HEALTHCAREHOSPITALS & CLINICS- Growing emphasis on preventive healthcare for patients with cardiovascular diseases to drive marketHOME CARE- Increasing need for remote monitoring of geriatric population susceptible to chronic diseases to foster segmental growthDIAGNOSTIC LABORATORIES- Rising burden of cancer to contribute to segmental growth
-
9.3 FITNESS & SPORTSINCREASING AWARENESS OF MONITORING PHYSIOLOGICAL PARAMETERS AMONG ATHLETES TO PROPEL MARKET
- 9.4 OTHER END USERS
- 10.1 INTRODUCTION
-
10.2 NORTH AMERICARECESSION IMPACT ON MARKET IN NORTH AMERICAUS- Increasing healthcare expenditure and elderly population to contribute to market growthCANADA- Surging demand for self-administered drug treatments from chronic disease patients to boost market growthMEXICO- Rising premature deaths caused by chronic diseases to fuel market growth
-
10.3 EUROPERECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN EUROPEGERMANY- Increasing investment in advanced healthcare systems to augment market growthUK- Growing burden of chronic diseases to contribute to market growthFRANCE- Rising geriatric population requiring long-term care to drive marketREST OF EUROPE
-
10.4 ASIA PACIFICRECESSION IMPACT ON MARKET IN ASIA PACIFICCHINA- Increasing diabetic population and chronic disease prevalence to drive marketJAPAN- Rising government initiative to modernize healthcare facilities to fuel market growthSOUTH KOREA- Growing medical tourism due to improved healthcare infrastructure to expedite market growthREST OF ASIA PACIFIC
-
10.5 ROWRECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN ROWSOUTH AMERICA- Rising disposable income and healthcare spending to contribute to market growthMIDDLE EAST- Growing emphasis on improving healthcare infrastructure to cater to patients with chronic diseases to support market growth- GCC countries- Rest of Middle EastAFRICA- Increasing implementation of strategies to tackle non-communicable diseases to drive market
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024
- 11.3 REVENUE ANALYSIS, 2019–2023
- 11.4 MARKET SHARE ANALYSIS, 2023
- 11.5 COMPANY VALUATION AND FINANCIAL METRICS
- 11.6 BRAND/PRODUCT COMPARISON
-
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT: KEY PLAYERS, 2023- Overall footprint- Type footprint- Application footprint- End user footprint- Wireless connectivity footprint- Region footprint
-
11.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING: START-UPS/SMES, 2023- Detailed list of key start-ups/SMEs- Competitive benchmarking of key start-ups/SMEs
-
11.9 COMPETITIVE SCENARIO AND TRENDSPRODUCT LAUNCHESDEALS
-
12.1 KEY PLAYERSABBOTT- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewDEXCOM, INC.- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewMEDTRONIC- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewINSULET CORPORATION- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewBOSTON SCIENTIFIC CORPORATION- Business overview- Products/Solutions/Services offered- Recent developments- MnM viewKONINKLIJKE PHILIPS N.V.- Business overview- Products/Solutions/Services offered- Recent developmentsBIOLINQ INCORPORATED- Business overview- Products/Solutions/Services offered- Recent developmentsZIO BY IRHYTHM TECHNOLOGIES, INC.- Business overview- Products/Solutions/Services offered- Recent developmentsGENTAG, INC.- Business overview- Products/Solutions/Services offeredVITALCONNECT- Business overview- Products/Solutions/Services offered- Recent developmentsTHE SURGICAL COMPANY- Business overview- Products/Solutions/Services offered- Recent developmentsSENSEONICS LTD.- Business overview- Products/Solutions/Services offered- Recent developmentsACTIVE ENVIRONMENTAL SOLUTIONS- Business overview- Products/Solutions/Services offered
-
12.2 OTHER PLAYERSSCOTTCAREVIVALNK, INC.BITTIUMCARDIOMOSEERS TECHNOLOGYSIGKNOWCORTRIUMQARDIO, INC.LIFESIGNALSBLUE SPARK TECHNOLOGIES, INC.EPICORE BIOSYSTEMSHIVOX BIOTEK INCIONTOPATCH
-
12.3 CDMO PLAYERSTAPECON, INC.LINXENSQUAD INDUSTRIESBENELI.COMHI-TECH PRODUCTS
- 13.1 INSIGHTS FROM INDUSTRY EXPERTS
- 13.2 DISCUSSION GUIDE
- 13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 13.4 CUSTOMIZATION OPTIONS
- 13.5 RELATED REPORTS
- 13.6 AUTHOR DETAILS
- TABLE 1 ELECTRONIC SKIN PATCH MARKET: RISK ASSESSMENT
- TABLE 2 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT ON MARKET
- TABLE 3 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE, 2023
- TABLE 4 ROLE OF COMPANIES IN ELECTRONIC SKIN PATCH ECOSYSTEM
- TABLE 5 MARKET: LIST OF PATENTS, 2022–2023
- TABLE 6 MARKET: LIST OF CONFERENCES AND EVENTS, 2024–2025
- TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 10 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 11 NORTH AMERICA: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
- TABLE 12 EUROPE: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
- TABLE 13 ASIA PACIFIC: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
- TABLE 14 ROW: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES
- TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
- TABLE 16 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
- TABLE 17 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 18 MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 19 MARKET, BY TYPE, 2020–2023 (MILLION UNITS)
- TABLE 20 MARKET, BY TYPE, 2024–2029 (MILLION UNITS)
- TABLE 21 MONITORING & DIAGNOSTIC: MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 22 MONITORING & DIAGNOSTIC: MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 23 MONITORING & DIAGNOSTIC: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 24 MONITORING & DIAGNOSTIC: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 25 THERAPEUTIC: MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 26 THERAPEUTIC: MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 27 THERAPEUTIC: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 28 THERAPEUTIC: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 29 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION)
- TABLE 30 MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION)
- TABLE 31 CONNECTED: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 32 CONNECTED: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 33 NON-CONNECTED: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 34 NON-CONNECTED: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 35 MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 36 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 37 DIABETES MANAGEMENT: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 38 DIABETES MANAGEMENT: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 39 CARDIOVASCULAR MONITORING: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 40 CARDIOVASCULAR MONITORING: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 41 GENERAL PATIENT MONITORING: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 42 GENERAL PATIENT MONITORING: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 43 TEMPERATURE SENSING: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 44 TEMPERATURE SENSING: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 45 ELECTRICAL STIMULATION: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 46 ELECTRICAL STIMULATION: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 47 IONTOPHORESIS: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 48 IONTOPHORESIS: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 49 SWEAT SENSING: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 50 SWEAT SENSING: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 51 WOUND MONITORING & TREATMENT: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 52 WOUND MONITORING & TREATMENT: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 53 MOTION SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 54 MOTION SENSING: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 55 OTHER APPLICATIONS: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 56 OTHER APPLICATIONS: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 57 MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 58 MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 59 MARKET, BY HEALTHCARE, 2020–2023 (USD MILLION)
- TABLE 60 ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, 2024–2029 (USD MILLION)
- TABLE 61 HEALTHCARE: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 62 HEALTHCARE: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 63 HOSPITALS & CLINICS: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 64 HOSPITALS & CLINICS: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 65 HOME CARE: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 66 HOME CARE: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 67 DIAGNOSTIC LABORATORIES: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 68 DIAGNOSTIC LABORATORIES: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 69 FITNESS & SPORTS: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 70 FITNESS & SPORTS: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 71 OTHER END USERS: MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 72 OTHER END USERS: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 73 MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 74 ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 75 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 76 NORTH AMERICA: MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 77 NORTH AMERICA: MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 78 NORTH AMERICA: MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 79 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 80 NORTH AMERICA: MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 81 NORTH AMERICA: MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION)
- TABLE 82 NORTH AMERICA: MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION)
- TABLE 83 NORTH AMERICA: MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 84 NORTH AMERICA: MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 85 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 86 EUROPE: MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 87 EUROPE: MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 88 EUROPE: MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 89 EUROPE: MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 90 EUROPE: MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 91 EUROPE: MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION)
- TABLE 92 EUROPE: MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION)
- TABLE 93 EUROPE: MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 94 EUROPE: MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 95 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 96 ASIA PACIFIC: MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 97 ASIA PACIFIC: MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 98 ASIA PACIFIC: MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 99 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 100 ASIA PACIFIC: MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 101 ASIA PACIFIC: MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION)
- TABLE 102 ASIA PACIFIC: MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION)
- TABLE 103 ASIA PACIFIC: MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 104 ASIA PACIFIC: MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 105 ROW: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION)
- TABLE 106 ROW: MARKET, BY REGION, 2024–2029 (USD MILLION)
- TABLE 107 ROW: MARKET, BY TYPE, 2020–2023 (USD MILLION)
- TABLE 108 ROW: MARKET, BY TYPE, 2024–2029 (USD MILLION)
- TABLE 109 ROW: MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
- TABLE 110 ROW: MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
- TABLE 111 ROW: MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION)
- TABLE 112 ROW: MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION)
- TABLE 113 ROW: MARKET, BY END USER, 2020–2023 (USD MILLION)
- TABLE 114 ROW: MARKET, BY END USER, 2024–2029 (USD MILLION)
- TABLE 115 MIDDLE EAST: MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
- TABLE 116 MIDDLE EAST: MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
- TABLE 117 ELECTRONIC SKIN PATCH MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020–2024
- TABLE 118 MARKET: DEGREE OF COMPETITION, 2023
- TABLE 119 MARKET: TYPE FOOTPRINT
- TABLE 120 MARKET: APPLICATION FOOTPRINT
- TABLE 121 MARKET: END USER FOOTPRINT
- TABLE 122 MARKET: WIRELESS CONNECTIVITY FOOTPRINT
- TABLE 123 MARKET: REGION FOOTPRINT
- TABLE 124 MARKET: LIST OF KEY START-UPS/SMES
- TABLE 125 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
- TABLE 126 MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2024
- TABLE 127 ELECTRONIC SKIN PATCH MARKET: DEALS, JANUARY 2020–APRIL 2024
- TABLE 128 ABBOTT: COMPANY OVERVIEW
- TABLE 129 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 130 ABBOTT: PRODUCT LAUNCHES
- TABLE 131 ABBOTT: DEALS
- TABLE 132 DEXCOM, INC.: COMPANY OVERVIEW
- TABLE 133 DEXCOM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 134 DEXCOM, INC.: PRODUCT LAUNCHES
- TABLE 135 DEXCOM, INC.: DEALS
- TABLE 136 DEXCOM, INC.: OTHERS
- TABLE 137 MEDTRONIC: COMPANY OVERVIEW
- TABLE 138 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 139 MEDTRONIC: PRODUCT LAUNCHES
- TABLE 140 MEDTRONIC: DEALS
- TABLE 141 MEDTRONIC: OTHERS
- TABLE 142 INSULET CORPORATION: COMPANY OVERVIEW
- TABLE 143 INSULET CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 144 INSULET CORPORATION: PRODUCT LAUNCHES
- TABLE 145 INSULET CORPORATION: DEALS
- TABLE 146 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
- TABLE 147 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 148 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES
- TABLE 149 BOSTON SCIENTIFIC CORPORATION: DEALS
- TABLE 150 BOSTON SCIENTIFIC CORPORATION: OTHERS
- TABLE 151 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
- TABLE 152 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 153 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
- TABLE 154 KONINKLIJKE PHILIPS N.V.: DEALS
- TABLE 155 KONINKLIJKE PHILIPS N.V.: OTHERS
- TABLE 156 BIOLINQ INCORPORATED: COMPANY OVERVIEW
- TABLE 157 BIOLINQ INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 158 BIOLINQ INCORPORATED: DEALS
- TABLE 159 ZIO BY IRHYTHM TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 160 ZIO BY IRHYTHM TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
- TABLE 161 ZIO BY IRHYTHM TECHNOLOGIES, INC.: PRODUCT LAUNCHES
- TABLE 162 ZIO BY IRHYTHM TECHNOLOGIES, INC.: DEALS
- TABLE 163 GENTAG, INC.: COMPANY OVERVIEW
- TABLE 164 GENTAG, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 165 VITALCONNECT: COMPANY OVERVIEW
- TABLE 166 VITALCONNECT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 167 VITALCONNECT: PRODUCT LAUNCHES
- TABLE 168 VITALCONNECT: DEALS
- TABLE 169 THE SURGICAL COMPANY: COMPANY OVERVIEW
- TABLE 170 THE SURGICAL COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 171 THE SURGICAL COMPANY: DEALS
- TABLE 172 THE SURGICAL COMPANY: EXPANSIONS
- TABLE 173 SENSEONICS LTD.: COMPANY OVERVIEW
- TABLE 174 SENSEONICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 175 SENSEONICS LTD.: DEALS
- TABLE 176 ACTIVE ENVIRONMENTAL SOLUTIONS: COMPANY OVERVIEW
- TABLE 177 ACTIVE ENVIRONMENTAL SOLUTIONS: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
- FIGURE 1 ELECTRONIC SKIN PATCH MARKET SEGMENTATION
- FIGURE 2 GDP DECLINE IN MAJOR ECONOMIES, 2021–2023
- FIGURE 3 MARKET: RESEARCH DESIGN
- FIGURE 4 MARKET: RESEARCH FLOW
- FIGURE 5 MARKET: BOTTOM-UP APPROACH
- FIGURE 6 MARKET: TOP-DOWN APPROACH
- FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE)
- FIGURE 8 MARKET: DATA TRIANGULATION
- FIGURE 9 MARKET: RESEARCH ASSUMPTIONS
- FIGURE 10 ELECTRONIC SKIN PATCH MARKET: RESEARCH LIMITATIONS
- FIGURE 11 MONITORING & DIAGNOSTIC TO ACCOUNT FOR LARGER MARKET SHARE IN 2024
- FIGURE 12 CONNECTED SEGMENT TO HOLD LARGER SHARE OF MARKET IN 2029
- FIGURE 13 HEALTHCARE TO RECORD HIGHEST CAGR IN MARKET, BY END USER, DURING FORECAST PERIOD
- FIGURE 14 DIABETES MANAGEMENT APPLICATION TO DOMINATE MARKET BETWEEN 2024 AND 2029
- FIGURE 15 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 16 INCREASING PREVALENCE OF DIABETES AND CARDIOVASCULAR DISEASES TO CREATE LUCRATIVE OPPORTUNITIES FOR PLAYERS IN MARKET
- FIGURE 17 MONITORING & DIAGNOSTIC SEGMENT TO REGISTER HIGHER CAGR FROM 2024 TO 2029
- FIGURE 18 CONNECTED SEGMENT TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD
- FIGURE 19 HEALTHCARE TO DOMINATE MARKET, BY END USER, DURING FORECAST PERIOD
- FIGURE 20 DIABETES MANAGEMENT TO HOLD LARGEST SHARE OF MARKET IN 2024
- FIGURE 21 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 22 ELECTRONIC SKIN PATCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 23 NUMBER OF PEOPLE WITH CHRONIC DISEASES IN US
- FIGURE 24 PROPORTION OF POPULATION AGED OVER 65 YEARS, 2050
- FIGURE 25 IMPACT ANALYSIS: DRIVERS
- FIGURE 26 IMPACT ANALYSIS: RESTRAINTS
- FIGURE 27 IMPACT ANALYSIS: OPPORTUNITIES
- FIGURE 28 IMPACT ANALYSIS: CHALLENGES
- FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
- FIGURE 30 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE, 2023
- FIGURE 31 AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023
- FIGURE 32 VALUE CHAIN ANALYSIS
- FIGURE 33 ELECTRONIC SKIN PATCH ECOSYSTEM
- FIGURE 34 INVESTMENT AND FUNDING SCENARIO, 2019–2023
- FIGURE 35 PATENTS APPLIED AND GRANTED, 2014–2023
- FIGURE 36 IMPORT DATA FOR HS CODE 901890-COMPLIANT INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2019–2023 (USD MILLION)
- FIGURE 37 EXPORT DATA FOR HS CODE 901890-COMPLIANT INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2019–2023 (USD MILLION)
- FIGURE 38 PORTER’S FIVE FORCES ANALYSIS
- FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
- FIGURE 40 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
- FIGURE 41 MONITORING & DIAGNOSTIC TO DOMINATE MARKET, BY TYPE, DURING FORECAST PERIOD
- FIGURE 42 CONNECTED SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2029
- FIGURE 43 DIABETES MANAGEMENT APPLICATION TO HOLD LARGEST MARKET SHARE IN 2029
- FIGURE 44 HEALTHCARE SEGMENT TO DOMINATE ELECTRONIC SKIN PATCH MARKET BETWEEN 2024 AND 2029
- FIGURE 45 HOME CARE SEGMENT TO EXHIBIT HIGHEST CAGR IN MARKET, BY HEALTHCARE, DURING FORECAST PERIOD
- FIGURE 46 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2029
- FIGURE 47 NORTH AMERICA: MARKET SNAPSHOT
- FIGURE 48 US TO HOLD LARGEST SHARE OF NORTH AMERICAN ELECTRONIC SKIN PATCH MARKET IN 2029
- FIGURE 49 EUROPE: MARKET SNAPSHOT
- FIGURE 50 UK TO RECORD HIGHEST CAGR IN EUROPEAN MARKET DURING FORECAST PERIOD
- FIGURE 51 ASIA PACIFIC: MARKET SNAPSHOT
- FIGURE 52 CHINA TO EXHIBIT HIGHEST CAGR IN MARKET FROM 2024 TO 2029
- FIGURE 53 ROW: MARKET SNAPSHOT
- FIGURE 54 SOUTH AMERICA TO EXHIBIT HIGHEST CAGR IN MARKET DURING FORECAST PERIOD
- FIGURE 55 ELECTRONIC SKIN PATCH MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2023
- FIGURE 56 MARKET SHARE ANALYSIS, 2023
- FIGURE 57 COMPANY VALUATION
- FIGURE 58 FINANCIAL METRICS
- FIGURE 59 BRAND/PRODUCT COMPARISON
- FIGURE 60 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 61 MARKET: OVERALL FOOTPRINT
- FIGURE 62 ELECTRONIC SKIN PATCH MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
- FIGURE 63 ABBOTT: COMPANY SNAPSHOT
- FIGURE 64 DEXCOM, INC.: COMPANY SNAPSHOT
- FIGURE 65 MEDTRONIC: COMPANY SNAPSHOT
- FIGURE 66 INSULET CORPORATION: COMPANY SNAPSHOT
- FIGURE 67 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- FIGURE 68 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- FIGURE 69 ZIO BY IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- FIGURE 70 SENSEONICS LTD.: COMPANY SNAPSHOT
The research process for this study included the systematic gathering, recording, and analysis of data about customers and companies operating in the electronic skin patch market. This research study involved the extensive use of secondary sources, directories, and databases (Factiva, Oanda, and OneSource) to identify and collect valuable information for this extensive, technical, market-oriented, and commercial market study. In-depth interviews were conducted with various primary respondents, including experts from core and related industries and preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. Key players in the market were identified through secondary research, and their market rankings were determined through primary and secondary research. This research included studying annual reports of top players and interviewing key industry experts, such as CEOs, directors, and marketing executives.
Secondary Research
Various secondary sources were referred to in the secondary research process to identify and collect information relevant to this study. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers, certified publications, and articles from recognized authors; directories; and databases. Secondary research was mainly done to obtain critical information about the industry’s supply chain, value chain, the pool of key players, and market classification and segmentation according to industry trends, geographic markets, and key developments from market- and technology-oriented perspectives.
Secondary sources included corporate filings (such as annual reports, investor presentations, and financial statements); trade, business, and professional associations; white papers; journals and certified publications; articles by recognized authors; gold-standard and silver-standard websites; directories; and databases. Data was also collected from secondary sources, such as the International Diabetes Federation (IDF), the International Trade Centre (ITC) (Switzerland), and the National Institute of Health (NIH).
Primary Research
Extensive primary research was conducted after understanding and analyzing the current scenario of the electronic skin patch market through secondary research. Several primary interviews were conducted with key opinion leaders from the demand and supply sides across four major regions: North America, Europe, Asia Pacific, and RoW. Approximately 25% of the primary interviews were conducted with the demand side, while 75% were conducted with the supply side. This primary data was collected mainly through telephonic interviews, which accounted for 80% of the total primary interviews. Questionnaires and e-mails were also used to collect data. In canvassing primaries, the report covers various departments within organizations, such as sales, operations, and administration, to provide a holistic viewpoint.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods have been used to estimate and forecast the size of the market and its segments and sub-segments listed in the report. Extensive qualitative and quantitative analyses have been carried out on the complete market engineering process to list the key information/insights pertaining to the electronic skin patch market.
Key players in the market have been identified through secondary research, and their rankings in the respective regions have been determined through primary and secondary research. This entire procedure involved the study of the annual and financial reports of top players and interviews with industry experts, such as chief executive officers, vice presidents, directors, and marketing executives, for quantitative and qualitative key insights. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. All parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data has been consolidated and enhanced with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Electronic Skin Patch Market: Bottom-Up Approach
The bottom-up approach has been employed to arrive at the overall size of the Electronic Skin Patch market from the revenues of key players and their share in the market.
Electronic Skin Patch Market: Top-Down Approach
In the top-down approach, the overall size of the electronic skin patch market was used to estimate the size of the individual markets (mentioned in the market segmentation) through percentage splits obtained from secondary and primary research. For calculating the size of specific market segments, the size of the most appropriate parent market was used to implement the top-down approach. The bottom-up approach was also implemented for the data extracted from the secondary research to validate the size of various segments and sub-segments of the market.
The market share of each company was estimated to verify the revenue share used earlier in the bottom-up approach. The data triangulation procedure and data validation through primaries determined and confirmed the individual market size in this study. The data triangulation procedure used for this study was explained in the next section.
Data Triangulation
After arriving at the overall size of the market from the estimation process explained above, the market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed (wherever applicable) to complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments. The data was triangulated by studying various factors and trends from the demand and supply sides. The size of the electronic skin patch market was validated using both top-down and bottom-up approaches.
Market Definition
An electronic skin patch is a thin, flexible device embedded with electronic components and sensors that adhere to the skin. It is designed to monitor physiological parameters, such as heart rate, glucose level, temperature, and motion. It also delivers therapeutic agents, including drugs or electrical stimulation, to the body. These patches often incorporate wireless communication capabilities, enabling real-time transmission of data to smartphones or other devices for monitoring or analysis. They offer non-invasive and continuous monitoring, making them valuable in healthcare, fitness, and research applications.
Key Stakeholders
- Raw material and manufacturing equipment suppliers
- Government bodies, venture capitalists, and private equity firms
- Regulatory bodies
- Integrated device manufacturers (IDMs)
- Electronic skin patch component-related intellectual property owners
- Electronic skin patch technology platform developers
- Electronic skin patch component manufacturers
- Distributors and retailers
- Research organizations
- Healthcare providers
- Industry associations and forums
- End users
Report Objectives
- To describe and forecast the electronic skin patch market size, by type, by application, by wireless connectivity and end user, in terms of value
- To describe and forecast the market size, by type, in terms of volume
- To forecast the market size across four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW), in terms of value
- To present detailed information regarding the major factors influencing the market (drivers, restraints, opportunities, and challenges)
- To provide an ecosystem analysis, case study analysis, patent analysis, technology analysis, average selling price analysis, Porter’s Five Forces analysis, and regulations pertaining to the market
- To offer a comprehensive overview of the value chain of the electronic skin patch ecosystem
- To critically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- To assess the opportunities for stakeholders and describe the competitive landscape of the market
- To analyze competitive developments, such as collaborations, agreements, partnerships, and product developments, in the market
- To evaluate the impact of the recession on the electronic skin patch market
Available Customizations
With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 7)
Growth opportunities and latent adjacency in Electronic Skin Patch Market